At the Heart of European Technology
Invoke Capital is a very different type of technology investor. Founded by one of Europe’s most successful technology entrepreneurs, Invoke invests in and supports world-leading fundamental technology businesses emerging across Europe.
Since 2012, Invoke has been instrumental in developing and scaling prominent UK tech companies from innovative start-ups out of Cambridge University into global businesses.
Our unique approach means we do not only provide capital, but also draw on the expertise of entrepreneurial founders, and their networks, to provide support to entrepreneurs helping them to develop their ideas and bring their technology to market.
To date the value of Invoke’s investment in its portfolio is more than $500m. Its portfolio companies include Luminance, an award-winning machine learning platform for the legal industry, and Darktrace, a world-leading cyber AI company.
Dr Mike Lynch OBE FREng FRS
Founder, Invoke Capital
Mike is a celebrated technologist and has a proven track record of identifying and monetising fundamental technologies.
Having pioneered three of the biggest success stories in UK tech – Autonomy, Blinkx and Darktrace – Mike is regarded as Britain's most established technology entrepreneur. Dr Lynch read Information Sciences at Cambridge University, where he also gained a Ph.D. and held a research fellowship in adaptive pattern recognition. In 1996 he founded Autonomy and served as its CEO for 15-years. During this time Autonomy became one of the UK's most successful technology companies on the FTSE100. It was acquired by HP for $11 billion in 2011.
Referred to as the UK’s answer to Bill Gates, Mike has won numerous awards. He was awarded an OBE for Services to Enterprise in 2006 and was elected to the Prime Minister’s Council for Science and Technology in 2011. Mike is a fellow of the Royal Academy of Engineering and an honorary fellow of Christ's College Cambridge. He was elected a Fellow of the Royal Society in April 2014 and a trustee of the National Endowment for Science Technology and the Arts ( NESTA ) in 2010.
Mike is a generous supporter of many causes, including the Royal Botanic Gardens - Kew, Cancer Research UK, Cambridge University, The Prince’s Trust’s technology group and a number of educational charities. He also contributes to conservation charities and preserves rare breeds.
Dr lynch won a scholarship to Bancroft’s School, Woodford.
Mike attended Christ’s College, University of Cambridge where he studied Natural Sciences and met Peter Rayner, his mentor in the signal processing laboratory of the engineering department.
After graduating, Mike went on to do a PhD in signal processing and connectionist models at Cambridge University and then undertook a research fellowship in adaptive pattern recognition.
In the late 1980s, Dr Lynch founded his first company, Lynett Systems, which produced designs and audio products for the music industry. One invention included an ADAS sampler for Atari, Mac and PC.
Dr Lynch founded Cambridge Neurodynamics, which specialised in computer-based fingerprint recognition. Customers included the South Yorkshire Police Department. Mike sold the company in 2005.
As a spinoff from Cambridge Neurodynamics, Dr Lynch founded Autonomy based on his research into adaptive pattern recognition at Cambridge University.
Mike served as CEO of Autonomy for over 15 years, in which time the company made a series of successful acquisitions including Virage, Verity and Interwoven, and became one of the UK’s most successful technology companies on the FTSE100.
Autonomy was acquired by HP for $11billion.
Mike founded Invoke Capital with the aim of investing and supporting fundamental technology business emerging across Europe.
Dr Lynch and his Invoke Capital investment firm announced its first investment in Darktrace, the world-leading cyber AI company of which Mike was a founding member. Darktrace now works with more than 4,000 organisations and employs over 1,300 employees in 44 offices globally.
Invoke Capital led the Series B investment round in Sophia Genetics, a Swiss genomics business that is now the European leader in data-driven medicine.
Dr Lynch’s investment firm helped to found Cambridge-borne start-up, Luminance, an artificial intelligence platform for lawyers. Luminance is now valued at over $100million and supports more than 250 law firms globally.
Invoke Capital invested in Featurespace, the leading machine learning company for fraud prevention, which was founded by Cambridge University Professor, Bill Fitzgerald.
The Latest From Invoke Insights
Dr Mike Lynch talks to The Critic's political editor, Graham Stewart, about the policies that need to change, and those that must be implemented, in order to deliver on the Government's ambition to establish a 'thriving tech sector' in the UK post-Brexit.
Dr Mike Lynch OBE discusses the strategic important of the UK's technology sector and why we must defend and bolster our tech companies if we want to protect Britain's sovereignty.